SCHEMBL14966971

SCHEMBL14966971

CCOC(=O)c1cc(Br)c(C(F)(F)F)nc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.56
IDO1 P14902 1/20 0.55
NPSR1 Q6W5P4 1/20 0.46
TBK1 Q9UHD2 1/20 0.45
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 7/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
HPGD P15428 3/20 0.43
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
ATM Q13315 1/20 0.43
MAPT P10636 3/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14966882 0.87 KDM4E (0.64) KDM4EIDO1NPSR1HSD17B10ALDH1A1
SCHEMBL30500676 0.85 SOS1 (0.48) KDM4EIDO1ALDH1A1NPC1HPGD
SCHEMBL25262355 0.85 SOS1 (0.48) KDM4EIDO1ALDH1A1NPC1HPGD
SCHEMBL22868094 0.83 KDM4E (0.49) KDM4EIDO1NPSR1ALDH1A1SMN1; SMN2
SCHEMBL14966784 0.82 KDM4E (0.57) KDM4EIDO1NPSR1TBK1HSD17B10
SCHEMBL14967150 0.81 KDM4E (0.53) KDM4EIDO1NPSR1TBK1HSD17B10
SCHEMBL14966810 0.80 KDM4E (0.52) KDM4EIDO1NPSR1TBK1HSD17B10
SCHEMBL14966945 0.79 KDM4E (0.51) KDM4EIDO1NPSR1TBK1HSD17B10
SCHEMBL16969103 0.78 IDO1 (0.61) KDM4EIDO1NPSR1HSD17B10ALDH1A1
SCHEMBL14966182 0.78 TBK1 (0.40) KDM4EIDO1TBK1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072882-A1 2 -AMINO- 1, 8 -NAPHTHYRIDINE-3 -CARBOXAMIDE DERIVATIVES AS ANTIMICROBIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-23 WO disclosed